Skip to main content

Limited Submission Opportunity: 2020 V Foundation Translational Research Awards-Adult Cancer Research

Feb. 27, 2020, 3:36 PM

This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.


Vanderbilt (VU and VUMC, collaboratively) may choose one nominee for the V Foundation 2020 Translational Cancer Research Grant Program. The Translational Research Award is a $600,000 grant awarded in three annual installments of $200,000. Indirect costs up to a maximum of 10 percent are permitted (total costs, including indirects, must not exceed $600,000.)

Definition of a translational research project: Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 3 years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.

Any area of adult cancer research is permitted. While not required, research on the biological basis of cancer disparities experienced by patients from minority ethnic or racial populations in areas related to causes, aggressiveness, treatment or relapse is encouraged. Cancers in which ethnic and racial disparities have previously been demonstrated include: lung and bronchus, colon and rectum, breast, prostate, uterine, cervix, stomach and liver. At least one of the highest ranked applications will be designated as the recipient of a Stuart Scott Memorial Fund Translational Research Award.

Note that this call is distinct from the V Foundation V Scholar and V Clinical Scholar awards. Contact for more information.

Eligibility criteria

By May 28, 2020, the applicant who will lead the proposed research team must meet all of the following:

  • Hold a tenure-track faculty position at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible to be principal investigator of the research team.
  • Be a U.S. citizen or have a legal permit to work in the United States (either temporary or permanent).

Internal selection process

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in a single PDF) to by 5 p.m. on March 23, 2020.

  1. Research plan including a summary budget (2 page maximum);
  2. Brief statement of support from department chair/center director;
  3. NIH Biosketch

Submissions should reference “2020 V Translational Research Award – Adult Cancer Research” in the subject line of the email. The selected nominee will need to submit a nomination form by April 16 and full application by May 28.

Please contact us at if you have any questions.